The NCI invites to join us at the 16th International Conference on Malignancies in HIV/AIDS (ICMH) previously named the International Conference on Malignancies in AIDS and Other Acquired Immunodeficiencies (ICMAOI). The meeting will take place October 23-24, 2017, at the Lister Hill Center Auditorium on the campus of the National Institutes of Health in Bethesda, Maryland.
This meeting is presented by the Office of HIV and AIDS Malignancy, National Cancer Institute, National Institutes of Health, U.S. Department of Health and Human Services.
Recent advances in areas such as viral oncology, immunology, genetics, epidemiology, pathogenesis, early diagnosis, and clinical investigation of malignant diseases associated with HIV and other acquired immunodeficiency states will be shared at this conference. Our objective is to facilitate the exchange of information between laboratory and clinical researchers so as to accelerate the translation of basic scientific discoveries into clinical applications.
Registration and further information on
World AIDS Day is 1st December each year, an opportunity for people worldwide to unite in the fight against HIV, show their support for people living with HIV and to commemorate people who have died.
This year, during the same week the WHO launched their 2016 global HIV progress report alongside their updated guidelines on HIV self-testing and partner notification.
Several IeDEA-WHO collaboration analyses from both the 2015 and 2016 rounds of this collaboration were cited in chapter three (Country action and WHO support) of this latest WHO progress report (see pages 28-30 & 38). Many thanks to the IeDEA teams for your continued commitment and support of this evolving and expanding collaboration with WHO.
IeDEA investigators had multiple abstract presentations and other invited talks throughout the pre-conference and main conference programs in July.
We were also invited to join the ALPHA network, the MeSH Consortium, and the HIV Modelling Consortium who hosted a booth in the Exhibition Hall where conference participants could learn more about how these collaborations are utilizing data to guide the global HIV response.
Read the slides “IeDEA at IAS 2016 – Durban, South Africa”
Misdiagnosis of HIV infection has important implications for individuals and for public health. With the exponential expansion of HIV testing using multiple technologies, the potential for both false positive and false negative results has similarly grown.
HIV testing technologies range from rapid diagnostic tests and other technologies that enable testing at the point-of-care or near point-of care, to those that are used exclusively in high-level facilities and laboratories. Although most technologies for HIV testing have high sensitivity and specificity and are highly accurate when used in a validated national algorithm, the volume of tests conducted (over 150 million tests in 2014 alone), could result in thousands of misdiagnosed cases, particularly if not conducted correctly.
Continue reading “JIAS Call for Papers: Misdiagnosis of HIV Infection”
The 8th International Workshop on HIV Pediatrics will be held in Durban, South-Africa on 15 and 16 July 2016.
As in previous years, the workshop is preceding the AIDS Conference. Make use of this opportunity to interact with a group of high-level experts, learn about the latest developments in the field, and discuss your findings with your international colleagues in an informal closed workshop setting!
Visit the website for more information:
In collaboration with the World Health Organization (WHO), the International Epidemiological Databases to Evaluate AIDS (IeDEA) research consortium provided essential data analyses to support the findings of the 2015 progress report entitled, “Global health sector response to HIV, 2000-2015: focus on innovations in Africa.”
This report provides insight to the progress and impact of the global public health response to HIV for the past fifteen years. IeDEA regions analyzed existing data from regional cohorts of people living with HIV at various phases in the continuum of care from diagnosis to viral suppression including retention in care and delays in diagnosis. In addition, the Southern Africa Region of IeDEA provided data on estimates of life expectancy of adults on antiretroviral treatment for cohorts in Southern Africa.
The report was released at the International Conference on AIDS and STIs in Africa (ICASA), and is available on the WHO website: